Plastic surgeons are spending a lot of time, money, and legislative effort to define themselves as the only physicians suitable to do cosmetic surgery. Words matter. Calling yourself a plastic surgeon is different from calling yourself an aesthetic surgeon, is different from calling yourself a cosmetic surgeon. Plastic surgeons apply the term solely to board-certified surgeons (plastic or facial plastic) who have completed a specific period of training and education and successfully completed the examinations offered by their board. A subset of plastic surgeons call themselves aesthetic surgeons, implying a higher artistic standard and maintain a separate professional organization. Plastic surgery, a term that derives from the Greek term plastikos (to shape or to mold), does not define an aesthetic purpose, rather a specific process. The subset of plastic surgeons who call themselves aesthetic surgeons are identifying the artistic aspects of their practice. According to the terms as found in the standard Merriam-Webster dictionary (see Table 1 ), calling yourself a "cosmetic surgeon" most closely aligns with what surgeons working to beautify their patients do: enhance appearance, including correcting defects, and create a visually appealing appearance. It is the diverse group of doctors who call themselves cosmetic surgeons, focusing on those procedures that enhance appearance and/or correcting defects (large nose, small breasts, etc) that have played a major role in the development of surgery that is used to enhance beauty. No specialty should or can own surgical procedures or limit access to the tools, pharmaceuticals, and devices essential to patient care.
The history of liposuction in the United States is a good example of how attitudes and opinions change over time. European surgeons perfected liposuction as a safe procedure during the 1970s and 1980s. Italian gynecologists Dr Georgio Fischer and Dr Arpad Fischer began using their technique for liposuction in 1976 and published their work 2 years later, describing a method of blunt closed liposuction. 1 The Fischers advanced the concept of liposuction as a sculpting tool in their article on riding breeches deformity 2 years later 2 by which time other surgeons were adopting the technique. William Coleman in his history of liposuction states that "the innovative work of the Fischers' was generally ignored by the plastic surgery community throughout the world." He attributes this to their formation of the International Association of Cosmetic Surgeons, which somehow was seen as an insult? or threat? Coleman postulates that is was their identification of themselves as cosmetic surgeons, and their interest in cosmetic surgery alone that contributed to this antithesis. 3 Liposuction was adopted quickly in France, promoted and modified by Drs Yves-Gerard Illouz and Pierre Fournier. Illouz, trained as a gynecologist, had identified as a purely cosmetic surgeon since 1962, and Fournier, trained as a general surgeon, also limited his practice to cosmetic surgery. Both were deeply involved in the early teaching of the technique to any interested visiting doctors. Interest in the United States came from a variety of surgeons in the fields of dermatology, gynecology, otolaryngology, and general surgery who began watching the European surgeons and introduced liposuction into the United States: Drs Lawrence Field in 1977, Lawrence Martin in 1980, and many others thereafter, including Richard Dolsky, Michael Elam, Rhoda Narins, and Fred Berkowitz. The history of the multispecialty evolution of plastic surgery and a detailed early history of the origins of cosmetic surgery as a specific field are well detailed by Richard Dolsky in his article celebrating the 25th anniversary of the American Academy of Cosmetic Surgery. 4 Probably the most significant advance in liposuction was provided by Dr Jeffrey Klein, a dermatologist who developed the use of tumescent local anesthesia. 5 This significantly improved both the efficacy and the safety of liposuction, making it one of the most frequently preformed surgical procedures in the world.
The successful removal of fat was followed by the use of the fat to augment soft tissue defects, first reported by Illouz in 1986. 6 The transfer of fat was adopted for a variety of cosmetic, congenital, and posttraumatic deformities. Basic scientists studying fat metabolism had recognized the presence of stem cells in human fat. [7] [8] [9] Illouz's publication of a large case series, 10 describing his safe and successful technique for the removal of adipose tissue, opened the door for research on human adipose-derived stem cells (ASCs). Thus, the advent of liposuction provided a safe, simple resource for harvesting these cells.
Similar to the success of liposuction as a cosmetic surgical technique, there has been an explosion of interest in ASCs. Although their role in regeneration and repair is still under investigation, they are already clinically offered across a wide spectrum. Patricia Zuk and colleagues first published accounts of stem cells, "multilineage cells found in fat," in 2001, postulating their use in multiple cell therapies. 11 A review article published in 2002 cautioned, "Further studies will facilitate the clinical and commercial development of adipose derived adult stem cells." 12 A recent article summarized the current registered clinical trials related to ASC and is found at http://www.ClinicalTrials.gov. 13 One hundred seventeen unique studies involved organ systems like heart, breast, and bone and disease states such as diabetes, arthritis, and wound healing. The marketing and applications of ASC use and the commercialization of stem cell processing have expanded rapidly, while the research is still seen as preliminary. There are already many clinics offering ASC autologous injections for a variety of conditions, ranging from back pain to diabetic ulcers. Leigh Turner, a bioethicist at the Center for Bioethics at the University of Minnesota, has been reporting on the use of stem cells, their clinical applications, and the regulatory environment around stem cell treatment for several years. 14 Because I know that many of my colleagues are actively using ASC in their clinical practices, I looked up his credentials and connections to the stem cell world. It was not surprising to find him embroiled in controversy as well as litigation over some of his comments on commercialized stem cell therapies. Turner has spoken and written frequently about the need to restrict and regulate stem cell therapies. A summary of one of his issues can be found in two 2012 articles in the MinnPost (a non-profit news organization) which outlines a dispute between Turner and Celltex. 15, 16 These articles highlight the conflict between stem cell clinicians, research and commercial interests, and the Food and Drug Administration (FDA) over what can/ should be the regulatory environment under which these therapies are carried out. Piqued by the dispute, the FDA investigated Celltex forcing changes in their business practices and treatments.
Turner's most recent article in Trends in Molecular Medicine 14 demonstrates that this conflict is still ongoing. In another recent article in Regenerative Medicine, 17 Turner continues his critique noting a particular point of contention: Devices used to extract stem cells from adipose tissue are not currently approved by the FDA for this type of point of care usage. Turner specifically cites cosmetic surgeons as one of the major marketing sources and goes on to discuss the "Position Statement on Stem Cells and Fat Grafting" released by the American Society of Plastic Surgeons (ASPS) and their analog, the American Society for Aesthetic Plastic Surgery (ASAPS). 18 Thus, the conflict between cosmetic and plastic continues. The "high ground" of plastic surgery citing FDA approvals, need for additional research, etc, overlooks their own Cosmetic: 1: of, relating to, or making for beauty especially of the complexion: beautifying 2: done or made for the sake of appearance: as a: correcting defects especially of the face b: decorative, ornamental c: not substantive: superficial 3: visually appealing Aesthetic: 1 a: of, relating to, or dealing with aesthetics or the beautiful b: artistic c: pleasing in appearance: attractive 2: appreciative of, responsive to, or zealous about the beautiful; also: responsive to or appreciative of what is pleasurable to the senses Plastic: 1: formative, creative 2 a: capable of being molded or modeled b: capable of adapting to varying conditions: pliable 3: sculptural 4: made or consisting of a plastic 5: capable of being deformed continuously and permanently in any direction without rupture 6: of, relating to, or involving plastic surgery 7: having a quality suggestive of mass-produced plastic goods; especially: artificial 4 8: relating to, characterized by, or exhibiting neural plasticity adoption of the process first brought to their attention by other fields.
The conflicts that exist among specialties first, over liposuction, and now over the use of stem cells derived from liposuction by-products are not likely to be resolved in the near future. Cutting-edge surgical research has long been derided by critiques that do not recognize the genius involved or the potential benefits to be achieved. A number of examples illustrate this.
Alexis Carrel developed vascular techniques for which he won a Nobel Prize in 1912 and went on with Charles Lindbergh (yes, that Charles Lindbergh) to invent a new organ perfusion machine in 1935, similar to the cardiac perfusion systems used in open-heart surgery. Their work was little recognized as their primary purpose, whole organ and whole limb transplantation, was widely discredited. Frederick Banting spent several years trying to interest a research laboratory in Toronto in his work on pancreatic exocrine function. Not until he convinced Rickard Macleod to accept a medical student, Charles Best, into his lab were they able to demonstrate the preparation and use of insulin. All three received the Nobel Prize in 1923. Werner Theodor Otto Forssmann was a surgical resident in 1929 when he performed a basilic vein cannulation into his own heart, a feat for which he was fired. Forssmann won the Nobel Prize-in 1956! Finally, Dr Harry Bunke, one of my personal heroes, was expelled from his lab where he was working on microanastomotic techniques using rabbit ears, continuing his research in his home garage. From there, he went on to perfect the 1-mm vessel anastomosis, making microsurgical replantation and transplantation possible.
Working outside the establishment, as many of our historical and now contemporary colleagues do, can be dispiriting. Professional shaming, litigation, regulatory intervention, and a host of other obstacles are part of the territory when cutting-edge work is made public. The many ethical issues that can be raised as well as legal barriers should not be ignored, and the rush to put profits over provable benefits needs careful consideration. But the horse is out of the barn, just as liposuction emerged from ridicule to a surgical juggernaut, it seems likely that stem cell therapies will emerge as useful in many conditions, ultimately accepted (though regulated) and honorably recognized. And plastic surgery should not be claiming either credit or control over it.
